Lundbeck engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. The Company offers pharmaceutical products for the treatment of Alzheimer's disease, depression, Parkinson's disease, Schizophrenia, alcohol dependence, anxiety, Bipolar I disorder, Epilepsy, Huntington’s disease, and symptomatic neurogenic orthostatic hypotension.